Today's Date
A Randomized, Placebo-Controlled, Open-Label, Does-Escalation Study Evaluating The Safety and Pharmacodynamics of Intranasal DV281 in Healthy Adults
(
TBD
)
ITN Protocol #:
ITN910AI
Branded Name:
TBD
Treatment Protocol #:
Therapeutic Area:
Autoimmune Disease
Current Status:
Development
Summary:
A Randomized, Placebo-Controlled, Open-Label, Does-Escalation Study Evaluating The Safety and Pharmacodynamics of Intranasal DV281 in Healthy Adults
Study Personnel:
